the Company completed the acquisition of Alimera Sciences. The transaction significantly expands the scope and scale of ANI’s ...

Ani Pharmaceuticals ( (ANIP) ) has released its Q3 earnings. Here is a breakdown of the information Ani Pharmaceuticals presented to its ...

“I am very pleased to report our third quarter results as we continue to execute against our purpose of ‘Serving Patients, Improving Lives,'” said Nikhil Lalwani, President & CEO of ANI ... the ...

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

New Delhi [India], October 28 (ANI): Certain areas of the national capital witnessed a layer of smog engulfing the area as the air quality remained in the 'Very Poor' category on Monday.

The court issued a contempt notice after Wikipedia failed to provide details on subscribers who edited the page of news agency ANI, which had filed a defamation suit against the platform. India likely ...

ANI’s Estradiol Gel, 0.06% is the generic version of the reference ... including statements regarding the benefits of the acquisition of Alimera Sciences. These forward-looking statements generally ...

ANI Pharmaceuticals (NASDAQ:ANIP) announced that following final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application, the company launched Estradiol Gel, 0.06% ...

ANI’s Estradiol Gel ... including statements regarding the benefits of the acquisition of Alimera Sciences. These forward-looking statements generally are identified by the words ...

ANI’s Estradiol Gel ... including statements regarding the benefits of the acquisition of Alimera Sciences. These forward-looking statements generally are identified by the words “believe ...